Takatsuki General Hospital Performs First Procedure With Stereotaxis Niobe(R) ES Technology in Japan
July 08, 2015 07:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 8, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that the first...
Stereotaxis to Present at Cantor Fitzgerald Inaugural Healthcare Conference in New York on July 8, 2015
July 02, 2015 07:45 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 2, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that William C. Mills,...
Stereotaxis to Present New Clinical Evidence and Product Innovations at Heart Rhythm 2015 in Boston
May 13, 2015 06:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 13, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it will...
Stereotaxis Reports 2015 First Quarter Financial Results
May 06, 2015 16:05 ET
|
Stereotaxis, Inc.
- Total Revenue Increased 14% over Prior Year First Quarter -
- System Revenue Increased 112% Year over Year -
- Operating Loss Decreased 37% Year over Year -
- Silicon Valley Bank...
Stereotaxis Elects Medical Device Industry Veteran Duane DeSisto to Board of Directors
May 04, 2015 06:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, May 4, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the election of medical...
Stereotaxis to Report First Quarter 2015 Financial Results on May 6, 2015
April 29, 2015 06:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, April 29, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq: STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will...
Stereotaxis Extends Silicon Valley Bank Credit Facility by Three Years
March 30, 2015 06:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 30, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that it has extended...
Florida Hospital First in U.S. to Use Stereotaxis Vdrive(R) Duo(TM) System to Control Multiple Diagnostic Devices
March 27, 2015 06:30 ET
|
Stereotaxis, Inc.
ST. LOUIS, March 27, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, and the Florida Hospital...
Stereotaxis Reports 2014 Fourth Quarter and Full Year Financial Results
February 25, 2015 16:05 ET
|
Stereotaxis, Inc.
-Achieves First Quarterly Operating Income in Company History-
-Increases Fourth Quarter Revenue 8% Year over Year and 10% Sequentially-
-Reports Record Annual Recurring Revenue of $27.2...
CHU de Saint-Etienne Launches Second Stereotaxis Lab
February 18, 2015 16:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) and Centre Hospitalier Universitaire (CHU) of Saint-Étienne, France, today announced the installation of the...